News FAMHP

There are 6 result(s) found based on your search criteria

1-6 from 6 result(s)

Register now for the online information session on the new European veterinary medicines legislation on 15 October 2021

On 15 October 2021, the FAMHP is organising an online information session on the European Regulation 2019/6 regarding veterinary medicines. The information session is intended for people working in the Belgian pharmaceutical industry.

Coronavirus: no shortage in medication supply, FAMHP closely monitoring the situation

Following the coronavirus epidemic (COVID-19), experts at FAMHP are actively monitoring the potential impact on the availability of medication and medical devices in Belgium. The FAMHP is also supporting the European Medicines Agency (EMA) in developing COVID-19 vaccines.

Save the date: Symposium on the new European legislation on veterinary medicines. What will change for you?

Europe has approved new legislation on veterinary medicines and medicated animal feeds. What does this mean and what will change concretely for the industry or veterinarian? Learn everything at the FAMHP symposium on November 19.

Recognition of the FAMHP by the American Food and Drug Administration (FDA)

The American Food and Drug Administration (FDA) has recognised the FAMHP as its Belgian counterpart under the mutual recognition agreement (MRA) between the European Union and the United States.

Good manufacturing practices for medicinal products available in French and Dutch

Until today, the good manufacturing practices (GMP) for medicinal products were only available in English. As of now, the GMP will be available in French and Dutch on the FAMHP website.

Présentation de la Fondation Non à la contrefaçon et à la piraterie : participation de l’AFMPS

La Fondation Non à la contrefaçon et à la piraterie est présentée à la presse ce 16 juin. A travers cette Fondation, l’Administration générale des douanes et accises et la Chambre de commerce internationale (ICC Belgique) veulent sensibiliser le public aux risques et dommages de la contrefaçon. L’année 2011, première année de fonctionnement de cette Fondation, est notamment consacrée au thème des médicaments contrefaits. Dans ce cadre, l’AFMPS tient à soutenir ses actions et à lui apporter ses compétences et sa collaboration.

1-6 from 6 result(s)